Research from Boston Children's Hospital suggests the possibility of restoring at least some visual function in people blinded by optic nerve damage from glaucoma, estimated to affect more than 4 million Americans, or from ...
Jan 14, 2016
0
1089
(Medical Xpress)—Optical illusions abound in human visual perception, as demonstrated by the following well-known examples. Although many are static illusions, motion illusions also occur. Recently, scientists at Université ...
(Medical Xpress)—Biogen Idec Inc has released preliminary results of a phase II clinical trial (called RENEW) meant to test the effectiveness of using an anti-LINGO-1 drug called BIIB033, to treat eye damage that occurs ...
Until now, the part of the ear that processes speech was poorly reflected in computer models, but University of Michigan researchers have figured out the math that describes how it works—which could help improve hearing ...
Jun 24, 2019
0
3
To understand how we see the world and how diseases such as age-related macular degeneration and glaucoma impair vision, scientists need to understand how the retina communicates vision signals to the brain.
Jun 15, 2020
0
74
A phase 1 clinical trial for the first treatment to reset the immune system of multiple sclerosis (MS) patients showed the therapy was safe and dramatically reduced patients' immune systems' reactivity to myelin by 50 to ...
Jun 5, 2013
0
0
(Medical Xpress)—For UCLA bioengineering professor Wentai Liu, more than two decades of visionary research burst into the headlines last month when the FDA approved what it called "the first bionic eye for the blind."
Mar 25, 2013
0
1
Electrical and chemical signals flash through our brains constantly as we move through the world, but it would take a high-speed camera and a window into the brain to capture their fleeting paths.
Mar 19, 2020
0
499
(Medical Xpress)—Researchers from Australia and the USA have made a unique discovery about how the brain computes sensory information.
Nov 15, 2012
1
0
A 28-patient phase 1 gene therapy clinical trial for the degenerative retinal disease Leber hereditary optic neuropathy (LHON) found no significant safety concerns; however, treatment failed to improve or slow vision loss, ...
Jun 2, 2022
0
2
